APH.L
Price:
$46.7
Market Cap:
$252.44M
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-11-22
Stock Exchange
LSE
Ticker
APH.L
According to Alliance Pharma plc’s latest financial reports and current stock price. The company's current ROE is -15.24%. This represents a change of 241.52% compared to the average of -4.46% of the last 4 quarters.
The mean historical ROE of Alliance Pharma plc over the last ten years is 5.09%. The current -15.24% ROE has changed -399.18% with respect to the historical average. Over the past ten years (40 quarters), APH.L's ROE was at its highest in in the June 2011 quarter at 5.27%. The ROE was at its lowest in in the December 2023 quarter at -17.55%.
Average
5.09%
Median
7.55%
Minimum
-15.21%
Maximum
14.21%
Discovering the peaks and valleys of Alliance Pharma plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 40.85%
Maximum Annual ROE = 14.21%
Minimum Annual Increase = -4774.14%
Minimum Annual ROE = -15.21%
Year | ROE | Change |
---|---|---|
2023 | -15.21% | -4774.14% |
2022 | 0.33% | -87.44% |
2021 | 2.59% | -9.31% |
2020 | 2.86% | -68.68% |
2019 | 9.12% | 25.33% |
2018 | 7.28% | -48.80% |
2017 | 14.21% | 40.85% |
2016 | 10.09% | 29.17% |
2015 | 7.81% | -34.05% |
2014 | 11.85% | -20.07% |
The current ROE of Alliance Pharma plc (APH.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-4.10%
5-year avg
-0.06%
10-year avg
5.09%
Alliance Pharma plc’s ROE is less than Advanced Medical Solutions Group plc (4.57%), less than iomart Group plc (5.24%), less than dotdigital Group Plc (11.80%), less than AB Dynamics plc (10.81%), greater than GB Group plc (-7.73%),
Company | ROE | Market cap |
---|---|---|
4.57% | $450.99M | |
5.24% | $108.90M | |
11.80% | $291.20M | |
10.81% | $453.35M | |
-7.73% | $848.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alliance Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alliance Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alliance Pharma plc's ROE?
How is the ROE calculated for Alliance Pharma plc (APH.L)?
What is the highest ROE for Alliance Pharma plc (APH.L)?
What is the 3-year average ROE for Alliance Pharma plc (APH.L)?
What is the 5-year average ROE for Alliance Pharma plc (APH.L)?
How does the current ROE for Alliance Pharma plc (APH.L) compare to its historical average?